HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Viganò, P Articles by Di Blasio, A M Search for Related Content PubMed PubMed Citation Articles by Viganò, P Articles by Di Blasio, A M

Department of Obstetrics, Gynecology and Neonatology, Fondazione Policlinico-Mangiagalli-Regina Elena Hospital, University of Milano, Milano, Italy
¹ Pathology Laboratory and Molecular Biology Laboratory, Istituto Auxologico Italiano, Via Zucchi, 18-Cusano Milanino, Milano, Italy
² Dept of Obstetrics and Gynecology, Clinica Macedonio Melloni, University of Milano, Milano, Italy
³ BioXell S.p.A, Milano, Italy

(Requests for offprints should be addressed to A M Di Blasio; Email: a.diblasio{at}auxologico.it)

In addition to its calciotropic function, the secosteroid 1,25-dihydroxyvitamin D₃ (1,25(OH)₂D₃), has potent anti-proliferative/immunomodulatory effects on various tissues. Consistently, the enzyme that catalyzes the synthesis of 1,25(OH)₂D₃, 1-hydroxylase (1-OHase) and the vitamin D receptor have a widespread tissue distribution. Among site-specific functions, the hormone has been suggested to be involved in uterine physiology. However, molecular analysis of the vitamin D system in normal endometrium throughout the menstrual cycle as well as its regulation in the context of endometrial physiological and pathological events have received very limited attention. Thus, we have studied expression, localization and regulation of 1-OHase in human cycling and early pregnant endometrium. The capacity for 1-hydroxylation and the presence of vitamin D receptor in endometrial cells have also been evaluated. The functional significance of these findings has been tested by evaluating gene expression of the catabolic enzyme, vitamin D 24-hydroxylase, and of the adhesion protein, osteopontin. Finally, to verify any potential dysfunction of the vitamin D system in endometriosis, a reproductive disease characterized by immune-mediated anomalies, we have analyzed expression of 1-OHase in both eutopic and ectopic endometrium of affected patients. Results obtained showed that the active form of the 1-OHase gene was expressed in human endometrial stromal cells independent of the cycle phase but with a significant increase in early pregnant decidua. A similar profile was observed for the protein, which was abundantly expressed in the cytoplasm of both endometrial stroma and epithelial glands. Both cycling and early pregnant endometrial cells also expressed the vitamin D receptor. In the same cells, 1-OHase mRNA levels were significantly stimulated by the pro-inflammatory cytokine interleukin (IL)-1ß (50 and 500 pg/ml) while addition of the active form of the hormone could modulate both CYP24 and osteopontin gene expression. The 1-OHase gene was also expressed in ectopic endometrium and its levels were increased in proliferative phase cultures derived from patients with endometriosis. Human cycling endometrium may be included among the extrarenal sites able to synthesize vitamin D. The IL-1ß-mediated induction of 1-OHase gene and the hormonal modulation of osteopontin support a role for the hormone in the immunological mechanisms underlying uterine function. Abnormalities of this system are present in endometriosis.

This article has been cited by other articles:

				B. Novakovic, M. Sibson, H. K. Ng, U. Manuelpillai, V. Rakyan, T. Down, S. Beck, T. Fournier, D. Evain-Brion, E. Dimitriadis, et al. Placenta-specific Methylation of the Vitamin D 24-Hydroxylase Gene: IMPLICATIONS FOR FEEDBACK AUTOREGULATION OF ACTIVE VITAMIN D LEVELS AT THE FETOMATERNAL INTERFACE J. Biol. Chem., May 29, 2009; 284(22): 14838 - 14848. [Abstract] [Full Text] [PDF]

				E. Somigliana, P. Panina-Bordignon, S. Murone, P. Di Lucia, P. Vercellini, and P. Vigano Vitamin D reserve is higher in women with endometriosis Hum. Reprod., August 1, 2007; 22(8): 2273 - 2278. [Abstract] [Full Text] [PDF]

				A. Agic, Hong Xu, C. Altgassen, F. Noack, M. M. Wolfler, K. Diedrich, M. Friedrich, R. N. Taylor, and D. Hornung Relative Expression of 1,25-Dihydroxyvitamin D3 Receptor, Vitamin D 1{alpha}-Hydroxylase, Vitamin D 24-Hydroxylase, and Vitamin D 25-Hydroxylase in Endometriosis and Gynecologic Cancers Reproductive Sciences, July 1, 2007; 14(5): 486 - 497. [Abstract] [PDF]

				P. Florio, M. Rossi, P. Vigano, S. Luisi, M. Torricelli, P. B. Torres, A. M. Di Blasio, and F. Petraglia Interleukin 1{beta} and Progesterone Stimulate Activin A Expression and Secretion From Cultured Human Endometrial Stromal Cells Reproductive Sciences, January 1, 2007; 14(1): 29 - 36. [Abstract] [PDF]